查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424031

單純皰疹病毒治療市場、份額、規模、趨勢、行業分析報告：類型、藥物、疫苗、給藥途徑、最終用途、地區、細分市場預測，2024-2032

Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球單純皰疹病毒治療市場規模預計將達到 46.6 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

病毒的高度傳染性迫使政府機構和民眾盡快尋求治療。 單純皰疹是一種病毒，根據其在人類中的流行情況可分為兩種類型。 HSV-1 通常透過與感染者的皮膚接觸而傳播。 另一方面，HSV-2 是一種唇皰疹，主要在兒童時期透過感染者唾液的非性接觸傳播。 需要有效治療單純皰疹病毒的一個主要因素是，一個人一旦被感染，它可能會持續一輩子。

當單純皰疹病毒進入人體時，它會建立一個潛在的網絡。 它會在大約一周到十天後消失，但鼻子和嘴巴周圍的皮膚可能會形成疼痛的水泡。 在某些情況下，單純皰疹會引起有害的腦炎和眼部感染。 據世界衛生組織（WHO）稱，單純皰疹病毒是社會上較常見的疾病，影響全球約三分之二的人口。 這凸顯了全球市場上單純皰疹病毒治療的性質。

不斷增加的研發活動旨在創新有可能治癒單純皰疹病毒治療的新療法，預計將為市場帶來巨大的成長機會。 例如，《自然通訊》2023 年發表的一項研究探討了細胞景觀與 1 型單純皰疹病毒之間的關係，發現兩者是相關的。 預計這些研究將在預測期內推動單純皰疹病毒治療的進展。

此外，對治療單純皰疹病毒的創新疫苗的投資不斷增加，也顯著推動了市場成長。 例如，深圳麥隆藥業與理性疫苗結成策略夥伴關係，在中國開發皰疹疫苗。

單純皰疹病毒治療市場報告亮點

由於其高感染率，單純皰疹病毒 1 (HSV-1) 預計在未來幾年將成長最快。

伐昔洛韋細分市場因其治療藥物的潛在高吸收率而佔據最大的市場份額。

由於存在與感染者接觸的風險，預計亞太地區在預測期內將出現最快的成長。

目錄

簡介

  • 報告說明
    • 研究目的
    • 市場範圍
    • 假設
  • 利害關係人

第 2 章執行摘要

第 3 章研究方法

第 4 章全球單純皰疹病毒治療市場洞察

  • 單純皰疹病毒治療 - 產業快照
  • 單純皰疹病毒治療市場動態
    • 促進因素和機會
      • 全球感染率上升
      • 探索細胞和基因療法的研究增加推動市場成長
    • 抑制因素和挑戰
      • 監管障礙可能會阻礙市場成長
  • PESTLE分析
  • 單純皰疹病毒治療產業的趨勢
  • COVID-19 感染的影響分析

第 5 章全球單純皰疹病毒治療市場（按類型）

  • 主要發現
  • 簡介
  • 單純皰疹病毒-1 (HSV-1)
  • 單純皰疹病毒 2 (HSV-2)

第 6 章全球單純皰疹病毒治療市場（按藥物）

  • 主要發現
  • 簡介
  • 阿昔洛韋
  • 伐昔洛韋
  • 泛昔洛韋
  • 其他藥物

第 7 章全球單純皰疹病毒治療市場（按疫苗）

  • 主要發現
  • 簡介
  • Simplylix
  • 其他

第 8 章全球單純皰疹病毒治療市場（依給藥途徑）

  • 主要發現
  • 簡介
  • 口頭
  • 注射
  • 局部

第 9 章全球單純皰疹病毒治療市場（依最終用途）

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 10 章全球單純皰疹病毒治療市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年單純皰疹病毒治療市場評估（按地區）
  • 單純皰疹病毒治療市場 - 北美
    • 北美：2019-2032 年單純皰疹病毒治療市場（按類型）
    • 北美：單純皰疹病毒治療市場，依給藥途徑劃分，2019-2032 年
    • 北美：單純皰疹病毒治療市場（按藥物），2019-2032 年
    • 北美：單純皰疹病毒治療市場（按疫苗），2019-2032 年
    • 北美：單純皰疹病毒治療市場（以最終用途），2019-2032 年
    • 單純皰疹病毒治療市場 - 美國
    • 單純皰疹病毒治療市場 - 加拿大
  • 單純皰疹病毒治療市場 - 歐洲
    • 歐洲：2019-2032 年單純皰疹病毒治療市場（按類型）
    • 歐洲：單純皰疹病毒治療市場（依給藥途徑），2019-2032 年
    • 歐洲：單純皰疹病毒治療市場（按藥物），2019-2032 年
    • 歐洲：單純皰疹病毒治療市場（按疫苗），2019-2032 年
    • 歐洲：單純皰疹病毒治療市場（以最終用途），2019-2032 年
    • 單純皰疹病毒治療市場 - 英國
    • 單純皰疹病毒治療市場—法國
    • 單純皰疹病毒治療市場 - 德國
    • 單純皰疹病毒治療市場—義大利
    • 單純皰疹病毒治療市場—西班牙
    • 單純皰疹病毒治療市場 - 荷蘭
    • 單純皰疹病毒治療市場—俄羅斯
  • 單純皰疹病毒治療市場 - 亞太地區
    • 亞太地區：單純皰疹病毒治療市場（按類型），2019-2032 年
    • 亞太地區：單純皰疹病毒治療市場（依給藥途徑），2019-2032 年
    • 亞太地區：單純皰疹病毒治療市場（按藥物），2019-2032 年
    • 亞太地區：單純皰疹病毒治療市場（按疫苗），2019-2032 年
    • 亞太地區：單純皰疹病毒治療市場（依最終用途），2019-2032 年
    • 單純皰疹病毒治療市場 - 中國
    • 單純皰疹病毒治療市場 - 印度
    • 單純皰疹病毒治療市場 - 日本
    • 單純皰疹病毒治療市場 - 馬來西亞
    • 單純皰疹病毒治療市場 - 印度尼西亞
    • 單純皰疹病毒治療市場 - 韓國
  • 單純皰疹病毒治療市場 - 中東和非洲
    • 中東和非洲：單純皰疹病毒治療市場（按類型），2019-2032 年
    • 中東和非洲：2019-2032 年單純皰疹病毒治療市場（依給藥途徑）
    • 中東和非洲：單純皰疹病毒治療市場（按藥物），2019-2032 年
    • 中東和非洲：單純皰疹病毒治療市場（按疫苗），2019-2032 年
    • 中東和非洲：單純皰疹病毒治療市場（以最終用途），2019-2032 年
    • 單純皰疹病毒治療市場 - 沙烏地阿拉伯
    • 單純皰疹病毒治療市場－阿拉伯聯合大公國
    • 單純皰疹病毒治療市場 - 以色列
    • 單純皰疹病毒治療市場—南非
  • 單純皰疹病毒治療市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年單純皰疹病毒治療市場（按類型）
    • 拉丁美洲：單純皰疹病毒治療市場，依給藥途徑劃分，2019-2032 年
    • 拉丁美洲：單純皰疹病毒治療市場（按藥物），2019-2032 年
    • 拉丁美洲：單純皰疹病毒治療市場（按疫苗），2019-2032 年
    • 拉丁美洲：單純皰疹病毒治療市場（以最終用途），2019-2032 年
    • 單純皰疹病毒治療市場 - 墨西哥
    • 單純皰疹病毒治療市場 - 巴西
    • 單純皰疹病毒治療市場—阿根廷

第 11 章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 12 章公司簡介

  • Apotex Inc.
  • Carlsbad Tech
  • Emcure Pharmaceuticals Ltd.
  • Fresenius Kabi AG
  • GSK plc
  • Glenmark Pharmaceuticals Inc.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceuticals Industries Ltd.
  • Viatris, Inc.
Product Code: PM4333

The global herpes simplex virus treatment market size is expected to reach USD 4.66 billion by 2032, according to a new study by Polaris Market Research. The report "Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The higher transmission potential of viruses is forcing government agencies and people to get treatment as quickly as possible. Herpes simplex is a virus that is divided into two types based on the infection rate among humans. HSV-1 is usually transmitted through skin-to-skin contact from the infected person. At the same time, HSV-2 is an oral herpes that mostly infects children during childhood due to non-sexual contact with the saliva of infected people. One of the major factors driving the need for efficient treatment of the herpes simplex virus is that if a person gets infected once, then it can last forever.

The herpes simplex virus builds a latent network once it gets inside the human body. While it is likely to vanish after a week to ten days, it can cause painful blisters on the skin around the nose and mouth. In some cases, herpes simplex may lead to harmful brain inflammation and eye infections. According to the World Health Organization, the herpes simplex virus is a more common disease in society, affecting about two-thirds of the world population. This is emphasizing the essence of herpes simplex virus treatment in the global market.

The growing research and development activities to innovate new therapies with the potential to cure herpes simplex virus treatment are expected to showcase significant growth opportunities in the market. For instance, a 2023 study published in Nature Communications explored the relationship between the cellular landscape and herpes simplex virus type 1 and revealed that both are connected. These research studies are expected to drive advancements in herpes simplex virus treatment during the forecast period.

Moreover, rising investments in innovative vaccines for the treatment of the herpes simplex virus are significantly driving market growth. For instance, Shenzhen Mellow Hope Pharm Industrial. & Rational Vaccines entered into a strategic collaboration to develop herpes vaccines in China.

Herpes Simplex Virus Treatment Market Report Highlights

The Herpes Simplex Virus-1 (HSV-1) segment is anticipated to witness the highest growth in the coming years due to the higher rate of transmission.

Valacyclovir segment accounted for the largest market share owing to the potential for a higher absorption rate of treatment.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the risk of contact with infected persons.

The global players include Apotex Inc., Carlsbad Tech, Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, GSK plc, Glenmark Pharmaceuticals Inc., & Novartis AG.

Polaris Market Research has segmented the herpes simplex virus treatment market report based on type, drug, vaccine, route of administration, end-use, and region:

Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Herpes Simplex Virus-1 (HSV-1)
  • Herpes simplex virus-2 (HSV-2)

Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Other Drugs

Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)

  • Simplirix
  • Others

Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Injectable
  • Topical

Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Herpes Simplex Virus Treatment Market Insights

  • 4.1. Herpes Simplex Virus Treatment - Industry Snapshot
  • 4.2. Herpes Simplex Virus Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The rising infection rate in the world
      • 4.2.1.2. The rising studies exploring cell and gene therapies are driving the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory hurdles are likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Herpes Simplex Virus Treatment Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Herpes Simplex Virus Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Herpes Simplex Virus-1 (HSV-1)
    • 5.3.1. Global Herpes Simplex Virus Treatment Market, by Herpes Simplex Virus-1 (HSV-1), by Region, 2019-2032 (USD Billion)
  • 5.4. Herpes simplex virus-2 (HSV-2)
    • 5.4.1. Global Herpes Simplex Virus Treatment Market, by Herpes simplex virus-2 (HSV-2), by Region, 2019-2032 (USD Billion)

6. Global Herpes Simplex Virus Treatment Market, by Drug

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • 6.3. Acyclovir
    • 6.3.1. Global Herpes Simplex Virus Treatment Market, by Acyclovir, by Region, 2019-2032 (USD Billion)
  • 6.4. Valacyclovir
    • 6.4.1. Global Herpes Simplex Virus Treatment Market, by Valacyclovir, by Region, 2019-2032 (USD Billion)
  • 6.5. Famciclovir
    • 6.5.1. Global Herpes Simplex Virus Treatment Market, by Famciclovir, by Region, 2019-2032 (USD Billion)
  • 6.6. Other Drugs
    • 6.6.1. Global Herpes Simplex Virus Treatment Market, by Other Drugs, by Region, 2019-2032 (USD Billion)

7. Global Herpes Simplex Virus Treatment Market, by Vaccine

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • 7.3. Simplirix
    • 7.3.1. Global Herpes Simplex Virus Treatment Market, by Simplirix, by Region, 2019-2032 (USD Billion)
  • 7.4. Others
    • 7.4.1. Global Herpes Simplex Virus Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Herpes Simplex Virus Treatment Market, by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • 8.3. Oral
    • 8.3.1. Global Herpes Simplex Virus Treatment Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 8.4. Injectable
    • 8.4.1. Global Herpes Simplex Virus Treatment Market, by Injectable, by Region, 2019-2032 (USD Billion)
  • 8.5. Topical
    • 8.5.1. Global Herpes Simplex Virus Treatment Market, by Topical, by Region, 2019-2032 (USD Billion)

9. Global Herpes Simplex Virus Treatment Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Herpes Simplex Virus Treatment Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Herpes Simplex Virus Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.5. Online Pharmacy
    • 9.5.1. Global Herpes Simplex Virus Treatment Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)

10. Global Herpes Simplex Virus Treatment Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Herpes Simplex Virus Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Herpes Simplex Virus Treatment Market - North America
    • 10.3.1. North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.3. North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.3.4. North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.3.5. North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.3.6. Herpes Simplex Virus Treatment Market - U.S.
      • 10.3.6.1. U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.3.7. Herpes Simplex Virus Treatment Market - Canada
      • 10.3.7.1. Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.4. Herpes Simplex Virus Treatment Market - Europe
    • 10.4.1. Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.6. Herpes Simplex Virus Treatment Market - UK
      • 10.4.6.1. UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.7. Herpes Simplex Virus Treatment Market - France
      • 10.4.7.1. France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.8. Herpes Simplex Virus Treatment Market - Germany
      • 10.4.8.1. Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.9. Herpes Simplex Virus Treatment Market - Italy
      • 10.4.9.1. Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.10. Herpes Simplex Virus Treatment Market - Spain
      • 10.4.10.1. Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.11. Herpes Simplex Virus Treatment Market - Netherlands
      • 10.4.11.1. Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.4.12. Herpes Simplex Virus Treatment Market - Russia
      • 10.4.12.1. Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.5. Herpes Simplex Virus Treatment Market - Asia Pacific
    • 10.5.1. Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.6. Herpes Simplex Virus Treatment Market - China
      • 10.5.6.1. China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.7. Herpes Simplex Virus Treatment Market - India
      • 10.5.7.1. India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.8. Herpes Simplex Virus Treatment Market - Japan
      • 10.5.8.1. Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.9. Herpes Simplex Virus Treatment Market - Malaysia
      • 10.5.9.1. Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.10. Herpes Simplex Virus Treatment Market - Indonesia
      • 10.5.10.1. Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.5.11. Herpes Simplex Virus Treatment Market - South Korea
      • 10.5.11.1. South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.6. Herpes Simplex Virus Treatment Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.6. Herpes Simplex Virus Treatment Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.7. Herpes Simplex Virus Treatment Market - UAE
      • 10.6.7.1. UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.8. Herpes Simplex Virus Treatment Market - Israel
      • 10.6.8.1. Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.6.9. Herpes Simplex Virus Treatment Market - South Africa
      • 10.6.9.1. South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • 10.7. Herpes Simplex Virus Treatment Market - Latin America
    • 10.7.1. Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.6. Herpes Simplex Virus Treatment Market - Mexico
      • 10.7.6.1. Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.7. Herpes Simplex Virus Treatment Market - Brazil
      • 10.7.7.1. Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
    • 10.7.8. Herpes Simplex Virus Treatment Market - Argentina
      • 10.7.8.1. Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Apotex Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Carlsbad Tech
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Emcure Pharmaceuticals Ltd.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Fresenius Kabi AG
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. GSK plc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Glenmark Pharmaceuticals Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Sanofi
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Teva Pharmaceuticals Industries Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Viatris, Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables

  • Table 1 Global Herpes Simplex Virus Treatment Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Herpes Simplex Virus Treatment Market, by Drug, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Herpes Simplex Virus Treatment Market, by Vaccine, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Herpes Simplex Virus Treatment Market, by End Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Herpes Simplex Virus Treatment Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 8 North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 9 North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 10 North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 11 U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 13 U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 14 U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 18 Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 19 Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 Canada: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 21 Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 23 Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 24 Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Europe: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 26 Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 28 Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 29 Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 30 Germany: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 31 France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 32 France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 33 France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 34 France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 France: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 37 UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 38 UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 39 UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 40 UK: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 41 Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 43 Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 44 Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 Italy: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 51 Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 53 Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 54 Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Spain: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 56 Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 58 Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 59 Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 60 Russia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 66 China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 67 China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 68 China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 69 China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 70 China: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 71 Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 73 Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 74 Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 75 Japan: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 77 India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 78 India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 79 India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 India: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 91 South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 93 South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 94 South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 95 South Korea: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 96 Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 98 Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 99 Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 100 Latin America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 101 Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 103 Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 104 Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 105 Brazil: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 106 Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 108 Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 109 Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 110 Mexico: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 111 Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 113 Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 114 Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 115 Argentina: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 121 UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 123 UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 124 UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 125 UAE: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 131 South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 133 South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 134 South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 135 South Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 136 Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
  • Table 138 Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
  • Table 139 Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
  • Table 140 Israel: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Herpes Simplex Virus Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Herpes Simplex Virus Treatment Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Drug
  • Figure 9. Global Herpes Simplex Virus Treatment Market, by Drug, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Vaccine
  • Figure 11. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Herpes Simplex Virus Treatment Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Route of Administration
  • Figure 15. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2021 & 2030 (USD Billion)